Gayer Charles K
Insider CIK 1800110 · BCRX Vice President and CCO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2025-12-22 | 2025-12-23 | 14,142 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2025-12-22 | 2025-12-23 | 50,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2025-12-22 | 2025-12-23 | 10,091 | — | $0 | 17,409 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2025-12-22 | 2025-12-23 | 10,091 | $5.04 | $50.9K | 902,583 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2025-12-22 | 2025-12-23 | 14,142 | $3.22 | $45.5K | 892,492 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2025-12-22 | 2025-12-23 | 50,000 | $5.51 | $275.5K | 952,583 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2025-12-19 | 2025-12-23 | 11,477 | $7.41 | $85.0K | 878,350 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-12-17 | 2025-12-19 | 986,950 | — | $0 | 986,950 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-12-17 | 2025-12-19 | 471,000 | — | $0 | 889,827 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2025-12-12 | 2025-12-16 | 8,181 | $7.57 | $61.9K | 418,827 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-12-19 | 2024-12-23 | 260,950 | — | $0 | 260,950 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-19 | 2024-12-23 | 2,461 | $7.39 | $18.2K | 423,546 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-12-19 | 2024-12-23 | 125,950 | — | $0 | 426,007 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2024-12-14 | 2024-12-17 | 8,251 | $7.53 | $62.1K | 300,057 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-13 | 2024-05-15 | 30,000 | $5.47 | $164.1K | 307,533 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-19 | 2023-12-20 | 2,482 | $6.05 | $15.0K | 274,533 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-12-14 | 2023-12-18 | 158,500 | — | $0 | 158,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2023-12-14 | 2023-12-18 | 5,840 | $6.43 | $37.6K | 277,015 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-12-14 | 2023-12-18 | 34,000 | — | $0 | 282,855 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-12-19 | 2022-12-21 | 158,500 | — | $0 | 158,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-12-19 | 2022-12-21 | 34,000 | — | $0 | 245,610 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-12-15 | 2022-12-19 | 6,100 | $10.90 | $66.5K | 211,610 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2022-01-13 | 80,000 | — | $0 | 216,556 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-12-14 | 2021-12-16 | 164,000 | — | $0 | 164,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2021-12-16 | 125,000 | — | $0 | 261,556 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-15 | 2020-12-17 | 190,000 | — | $0 | 190,000 | SEC↗ |